ARVO Meeting

ARVO calls for applications for Dr. David L. Epstein AwardAt its 2017 general business meeting in May, the Association for Research in Vision and Ophthalmology (ARVO) welcomed a new president, Claude F. Burgoyne, MD, FARVO. Dr. Burgoyne, a glaucoma clinician and surgeon, is senior scientist, Van Buskirk Chair for Ophthalmic Research, and director of the Optic Nerve Head Research Laboratory at Devers Eye Institute, Portland, OR. He also serves as clinical professor of ophthalmology at Oregon Health and Sciences University, Eugene.
ARVO 2017 showcases vision research advancesAdvances in presbyopia, dry eye and allergy, and age-related macular degeneration filled this year’s meeting of the Association for Research in Vision and Ophthalmology.
10 things you may have missed at ARVO
10 things you may have missed at ARVOFrom blueberries for dry eye, to advances in "robotic" vision, here are some highlights from ARVO 2016.
ARVO 2013: Sight set on world-class scienceThough the scenic backdrop of the Pacific Northwest at this year’s meeting of the Association for Research in Vision and Ophthalmology (ARVO) may have been different from the traditional Floridian seascape, the meeting’s world-class science continues to be at the forefront.
Slow-release therapy for AMD, DME on horizonSlow release of surrogate proteins over several months has been demonstrated in vitro from injectable hydrogel depots. This technology could help create long-term, sustained-release treatments of anti-vascular endothelial growth factor drugs.
Meaningful pharmacologic pupil dilation possible after deathPupils can be pharmacologically dilated after death, according to the results of a recent study. The study examined pupillary dilation of postmortem eye bank eyes, which may facilitate postmortem examination and screening through modalities such as fundus photography and fundus optical coherence tomography.
Integrin peptide for AMD emergingIn the first clinical trial of ALG-1001 in wet AMD, there was an apparent clinical benefit to patients, as evidenced by improvements from baseline visual acuity and macular anatomy.
How emixustat hydrochloride may help geographic atrophyDrug modulates visual cycle activity, reduces oxidative stress, slows accumulation of toxins
Estrogen, POAG link exploredData analyses found a strong association in women between estrogen metabolism pathway single-nucleotide polymorphisms and high-pressure, open-angle glaucoma.
Faces detected with retinal prosthesisNew data show that a retinal prosthesis system is capable of providing face detection functionality to blind individuals, said Paulo E. Stanga, MD.